DEC 16, 2019 1:17 PM PST

Drug Targets Against The Nipah Virus

WRITTEN BY: Nouran Amin

The Nipah virus, first identified in 1998 and is transmitted from pigs and bats, has resulted in a high mortality rate killing more than half of all infected individuals in Bangladesh and India. Although, there has not been more than 150 fatalities from the virus, it is still a deadly threat that may lead to a pandemic. To counteract that issue, researchers have examined the molecular structure of the virus to come up with 150 possible drug targets.

Learn more about the Nipah virus:

The drug targets identified were possible inhibitors of the virus that block its detrimental effects. In the study, researchers from the Indian Institute of Science Education first modeled in 3D nine Nipah virus proteins before designing inhibitory molecules that block the activity of the protein. They then tested the efficacy of these inhibitors on 15 different viral strains.

Using computational analysis, they identified 4 putative peptides inhibitor therapeutics against the Nipah virus protein products and an additional 146 small molecule inhibitors. Overall, thirteen compounds were believed to the most promising based on characteristics such as strength, stability, and effectiveness against variable Nipah viral strains.

"We conclude that it is highly likely that the proposed inhibitors would be potent against all strains of the virus Nipah and other related zoonotic viruses that pose a serious epidemic threat," the researchers say. "Computational approaches can help identify and design inhibitors that could be rapidly tested or even deployed."

Findings were published in the journal, PLOS Neglected Tropical Diseases.

Source: Science Daily

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
NOV 03, 2020
Cardiology
A New Peptide Could Help Repair and Protect the Heart During Ischemia Reperfusion Injury
NOV 03, 2020
A New Peptide Could Help Repair and Protect the Heart During Ischemia Reperfusion Injury
Cardiovascular disease is one of the most common causes of death in the world. Although we have many treatments against ...
NOV 17, 2020
Drug Discovery & Development
Antibiotics Before Age 2 Linked to Childhood Health Conditions
NOV 17, 2020
Antibiotics Before Age 2 Linked to Childhood Health Conditions
Researchers from Mayo Clinic have found a link between children aged two and under taking antibiotics and an increased r ...
NOV 02, 2020
Drug Discovery & Development
Potential Therapy for Alzheimer Disease
NOV 02, 2020
Potential Therapy for Alzheimer Disease
A main characteristic of Alzheimer disease is an aggregate of a protein (peptide) clump in the brain leading to memory l ...
JAN 03, 2021
Drug Discovery & Development
How Psychedelic Salvinorin A Works in the Brain
JAN 03, 2021
How Psychedelic Salvinorin A Works in the Brain
Despite increasing interest in hallucinogens, the effects of Salvinorin A, a drug used in Native Mexican rituals, have r ...
JAN 05, 2021
Neuroscience
Synthetic Psychedelic Treats Depression Without Hallucinations
JAN 05, 2021
Synthetic Psychedelic Treats Depression Without Hallucinations
Psychedelics are receiving an increasing amount of attention- both in research and in the media- for their potential to ...
JAN 20, 2021
Microbiology
Cannabis Compound Could Lead to New Class of Antibiotics
JAN 20, 2021
Cannabis Compound Could Lead to New Class of Antibiotics
For the first time, a synthetic version of a non-psychoactive molecule found in marijuana has been shown to kill pathoge ...
Loading Comments...